Sernova Corp. buy Bue92
Summary
This prediction ended on 15.06.22 with a price of €0.83. With a performance of -6.12%, the BUY prediction by Bue92 finished with a loss. Bue92 has 100% into this predictionSernova Corp (WKN A0LBCR) is an innovative biotechnology company specializing in the development of regenerative medicine therapies. Focused on improving the treatment of chronic diseases, Sernova utilizes its proprietary Cell Pouch System™ - an implantable and scalable medical device - to house therapeutic cells for the long-term treatment of metabolic, hematologic, and neurological disorders. Listed on various stock exchanges, including Canada's TSX Venture Exchange (TSX-V), the Frankfurt Stock Exchange (FRA), and U.S. OTC (OTC:SEOVF), Sernova is driven by a mission to dramatically improve the outcomes and lives of individuals living with chronic diseases, while simultaneously offering a lucrative investment opportunity for those that believe in the potential of regenerative medicine.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Sernova Corp. | -6.759% | -6.759% | -48.392% |
| iShares Core DAX® | 1.804% | -0.748% | 13.168% |
| iShares Nasdaq 100 | -0.182% | -3.412% | 39.976% |
| iShares Nikkei 225® | 0.413% | -7.381% | 18.776% |
| iShares S&P 500 | 0.664% | -1.941% | 28.141% |